{"entity":{"type":"insider","cik":"0001378005","url":"/insider/0001378005","json_url":"/insider/0001378005.json","name":"Invus C.V.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2010-03-19","last":"2014-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Invus C.V.","source":"filing","n_filings":2,"first_seen":"2014-12-10","last_seen":"2014-12-12"},{"name":"Invus, CV","source":"filing","n_filings":2,"first_seen":"2010-03-19","last_seen":"2012-10-25"}],"transactions":[{"id":7035962,"accession":"0001209191-14-075102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-075102","line_url":"/filing/0001209191-14-075102#line-1","is_derivative":false,"issuer_cik":"0001053890","issuer_name":"LEXICON PHARMACEUTICALS, INC.","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001053890","owner_cik":null,"owner_name":"Invus C.V.; Ulys, L.L.C.; DEBBANE RAYMOND","owner_display_name":"Invus C.V.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":0.8802,"price_display":"0.88","price_state":"stated","total_value":132030.0,"total_display":"132,030.00","total_whole":"132,030","shares_owned_after":30248505.0,"shares_owned_after_display":"30,248,505","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-12","scope":"insider"},{"id":6742689,"accession":"0001209191-14-074332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-074332","line_url":"/filing/0001209191-14-074332#line-1","is_derivative":false,"issuer_cik":"0001053890","issuer_name":"LEXICON PHARMACEUTICALS, INC.","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001053890","owner_cik":null,"owner_name":"Invus C.V.; Ulys, L.L.C.; DEBBANE RAYMOND","owner_display_name":"Invus C.V.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":315896.0,"shares_display":"315,896","price_per_share":0.9033,"price_display":"0.90","price_state":"stated","total_value":285348.8568,"total_display":"285,348.86","total_whole":"285,349","shares_owned_after":30098505.0,"shares_owned_after_display":"30,098,505","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-10","scope":"insider"},{"id":3238121,"accession":"0001181431-12-055550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-055550","line_url":"/filing/0001181431-12-055550#line-1","is_derivative":false,"issuer_cik":"0001053890","issuer_name":"LEXICON PHARMACEUTICALS, INC./DE","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001053890","owner_cik":null,"owner_name":"Ulys, L.L.C.; DEBBANE RAYMOND; Invus, CV","owner_display_name":"Ulys, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000000.0,"shares_display":"3,000,000","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":6750000.0,"total_display":"6,750,000.00","total_whole":"6,750,000","shares_owned_after":283154744.0,"shares_owned_after_display":"283,154,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-10-23","filed_date":"2012-10-25","scope":"insider"},{"id":7585797,"accession":"0001181431-10-017475","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-017475","line_url":"/filing/0001181431-10-017475","is_derivative":false,"issuer_cik":"0001053890","issuer_name":"LEXICON PHARMACEUTICALS, INC./DE","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001053890","owner_cik":null,"owner_name":"DEBBANE RAYMOND; Invus, L.P.; Invus Advisors, L.L.C.; Ulys, LLC; Invus, CV","owner_display_name":"DEBBANE RAYMOND","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":94270206.0,"shares_display":"94,270,206","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":108410736.9,"total_display":"108,410,736.90","total_whole":"108,410,737","shares_owned_after":130137040.0,"shares_owned_after_display":"130,137,040","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-19","filed_date":"2010-03-19","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001062822","name":"LEXICON PHARMACEUTICALS, INC.","url":"/issuer/0001062822","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2010-03-19","last_seen":"2014-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378005","retrieved_at":"2026-08-26T12:01:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}